|
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> Canada Offers Guidance on Evidence for Class III, IV Device Applications
FDAnews Device Daily Bulletin
Aug. 23, 2012
| Vol.
9 No.
166
Canada Offers Guidance on Evidence for Class III, IV Device Applications
Makers of Class IV devices that choose not to use a summary technical documentation-based license or amendment application must provide details on manufacturing and quality controls, a device-specific quality plan and process validation studies, according to a Health Canada final guidance. Applicants should also include a risk assessment and risk-reduction measures that satisfy the agency’s safety and efficacy requirements.
International Medical Device Regulatory Monitor |
Related Articles
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.